SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

UnitedHealth Group, Inc. engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum's capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience. The OptumHealth segment provides health and wellness care, serving the broad health care marketplace including payers, care providers, employers, government, life sciences companies, and consumers. The OptumInsight segment focuses on data and analytics, technology, and information to help major participants in the healthcare industry. The OptumRx segment offers pharmacy care services. The company was founded by Richard T. Burke in January 1977 and is headquartered in Eden Prairie, MN.

Unitedhealth Group Inc

UnitedHealth Group is trending sharply lower following the Trump administration's proposed flat Medicare Advantage payment rates for 2027, significantly below Wall Street's growth expectations, and the company's softer-than-expected 2026 revenue guidance. This has ignited a fierce debate, with many investors anticipating a long-term re-rating for the healthcare sector due to persistent political pressure, while others are aggressively buying the dip, viewing the sharp sell-off as an attractive long-term opportunity.

Redwire Corp. manufactures and supplies space equipment. It offers critical space solutions and reliability components for the next generation space economy with IP for solar power generation and in-space 3D printing and manufacturing. It assists its customers in solving challenges of future space missions. The company was founded in 2020 and is headquartered in Jacksonville, FL.

Redwire Corporation

Redwire Corp

Redwire (RDW) is generating significant buzz following news of its selection for the Missile Defense Agency's SHIELD IDIQ contract, boasting a $151 billion ceiling and tying into the 'Golden Dome' initiative. The community is actively discussing this major defense win, with many anticipating a substantial growth trajectory and potential short squeeze, despite some noting the contract does not guarantee immediate revenue. This positions RDW as a key player attracting strong momentum in the evolving space and defense sector.

The Trade Desk, Inc. engages in the provision of a self-service and cloud-based ad-buying platform. It operates through the United States and International geographical segments. The firm offers omnichannel advertising, audience targeting, solutions for identity, application programming interface (API), custom, and programmatic, measurement and optimization. The company was founded by Jeffrey Terry Green and David Pickles in November 2009 and is headquartered in Ventura, CA.

Trade Desk Inc - Ordinary Shares - Class A

Trade Desk Inc

The Trade Desk is trending due to significant market uncertainty following an abrupt CFO departure and a rescheduled earnings announcement. Community members are expressing frustration over perceived management inaction, questioning the company's competitive stance against 'walled garden' platforms, and speculating about potential buyouts amidst the stock's multi-year lows.

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

GameStop is trending following news that prominent investor Michael Burry has acquired shares, articulating a long-term value thesis focused on the company's robust cash position and strategic potential under Ryan Cohen, rather than meme-stock speculation. This has ignited fervent discussion within the community, with many celebrating the perceived validation, while others remain skeptical of sustained price action, still debating the role of past short squeezes versus a fundamental value turnaround.

BiomX, Inc. operates as a clinical-stage microbiome company, which engages in the development of both natural and engineered phage cocktails designed to target and destroy harmful bacteria in chronic diseases, such as cystic fibrosis and atopic dermatitis. Its product pipelines include BX004 and BX005, which are treatments for cystic fibrosis and atopic dermatitis respectively. The company was founded in March 2015 and is headquartered in Ness Ziona, Israel.

BiomX Inc

BiomX Inc. is experiencing significant premarket volatility and multiple trading halts following an SEC filing disclosing Pyu Pyu Capital's 19.99% stake. This news, stemming from a previous private placement, is fueling widespread speculation among retail traders about a potential short squeeze due to the stock's low float and drawing comparisons to other recent high-flying names. The community is actively discussing both the potential for substantial gains and skepticism regarding current valuations.

Intellia Therapeutics, Inc. is a clinical stage genome editing company, which engages in the development of curative therapeutics using the CRISPR/Cas9 system. Its CRISPR/Cas9 system transforms medicine by both producing therapeutics that permanently edit and/or correct disease-associated genes in the human body with a single treatment course, and creates engineered cells that can treat oncological and immunological diseases. The company was founded by Andrew May, Luciano Marraffini, Rodolphe Barrangou, Nessan Bermingham, Rachel Haurwitz, Erik Sontheimer, Jennifer Doudna, and Derrick Rossi in May 2014 and is headquartered in Cambridge, MA.

Intellia Therapeutics Inc

Intellia Therapeutics is surging after the FDA lifted the clinical hold on its pivotal Phase 3 trial for nexiguran ziclumeran, eliminating a significant regulatory hurdle. This crucial development is exciting investors, who are discussing the potential for a substantial short squeeze and a positive ripple effect across the broader gene-editing sector. Community sentiment suggests confidence is returning as the initial patient death associated with the hold was reportedly unrelated to the therapy, clarifying the path forward for the CRISPR-based treatment.

BlackRock Institutional Trust Company N.A. - iShares Silver Trust

iShares Silver Trust

The iShares Silver Trust ($SLV) is experiencing extreme volatility driven by a rumored leaked memo detailing a massive institutional short position and ongoing discussions about tightening supply from industrial demand and Chinese export controls. Community sentiment is fiercely divided, with aggressive bullish calls for a historic short squeeze and further upside amidst de-dollarization, clashing with strong bearish predictions of a blow-off top and an imminent correction. This intense battle is generating significant price swings, with both "dip buying" and "short of a lifetime" narratives dominating conversations.

USA Rare Earth, Inc. is domestic supplier of rare earth magnets and heavy rare earth elements. It is developing a vertically integrated, domestic supply chain for rare earth element magnet production, with a facility in Stillwater, Oklahoma, and mining rights to the Round Top heavy rare earth and critical minerals deposit in West Texas. The company was founded in May 2019 and is headquartered in Stillwater, OK.

USA Rare Earth Inc. - Ordinary Shares - Class A

USA Rare Earth Inc

USA Rare Earth is trending following significant government and private funding commitments aimed at bolstering its domestic critical mineral and magnet supply chain. The community is buzzing about a substantial $1.6 billion U.S. government investment and a $1.5 billion private placement, which has prompted several analyst upgrades. Despite experiencing sharp price volatility and attributed aggressive shorting, many investors are debating whether current price action represents a long-term opportunity given the strategic national importance of rare earths.

D-Wave Quantum, Inc. engages in the development and delivery of quantum computing systems, software, and services. It provides customers with access to the company’s quantum computing systems via the cloud in the form of quantum computing as a service. It offers professional services such as customer assistance in identifying and implementing quantum-computing applications. The company was founded on January 25, 2022 and is headquartered in Palo Alto, CA.

D-Wave Quantum Inc

D-Wave Quantum is trending as recent agreements for quantum computing systems with a prominent university and expanded defense industry collaborations ignite community enthusiasm. Discussions are intensifying around the company's strategic relocation and dual-platform technological advancements, with market participants keenly anticipating further updates from an ongoing industry conference while weighing future potential against current valuation concerns.

Humana Inc. engages in the provision of health insurance services. It operates through the Insurance and CenterWell segments. The Insurance segment consists of Medicare benefits, marketed to individuals or directly via group Medicare accounts, as well as contract with CMS to administer the Limited Income Newly Eligible Transition, or LI-NET, prescription drug plan program and contracts with various states to provide Medicaid, dual eligible demonstration, and Long-Term Support Services benefits, which refer to as state-based contracts. The CenterWell segment represents payor-agnostic healthcare services offerings, including pharmacy dispensing services, provider services, and home services. The company was founded by David A. Jones, Sr., and Wendell Cherry on August 18, 1961 and is headquartered in Louisville, KY.

Humana Inc.

Humana Inc

Humana is trending significantly after the Centers for Medicare & Medicaid Services proposed a near-flat payment increase for 2027 Medicare Advantage plans, starkly missing market expectations and disproportionately impacting the company's MA-dependent business model. The community is sharply divided, with intense bearish sentiment and discussions about further downside contrasting with widespread calls to 'buy the dip' amidst perceived market overreaction to the regulatory shock.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 
